Skip to content

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.6×+0.2×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
94.1×+93.1×
CorMedix logo
CorMedixCRMD
1.2×-2.3×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
3.4×-0.7×
Opko Health logo
Opko HealthOPK
0.7×-0.1×

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's price / book?
Emergent Biosolutions (EBS) reported price / book of 0.8× in Q1 2026.
How has Emergent Biosolutions's price / book changed year-over-year?
Emergent Biosolutions's price / book increased by 71.5% year-over-year, from 0.5× to 0.8×.
What is the long-term trend for Emergent Biosolutions's price / book?
Over 5 years (2020 to 2025), Emergent Biosolutions's price / book has grown at a -17.9% compound annual growth rate (CAGR), from 3.3× to 1.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.